相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice
Taisuke Sakanaka et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
Rosa Barreira da Silva et al.
NATURE IMMUNOLOGY (2015)
Dipeptidyl-Peptidase-4 Inhibitor, Alogliptin, Attenuates Arterial Inflammation and Neointimal Formation After Injury in Low-Density Lipoprotein (LDL) Receptor- Deficient Mice
Koji Akita et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Alogliptin: a new dipeptidyl peptidase-4 inhibitor with potential anti-atherogenic properties
Eiji Kutoh et al.
ENDOCRINE RESEARCH (2015)
Prolyl Carboxypeptidase Activity Decline Correlates with Severity and Short-Term Outcome in Acute Ischemic Stroke
Kaat Kehoe et al.
NEUROCHEMICAL RESEARCH (2015)
Increased plasma DPP4 activities predict new-onset atherosclerosis in association with its proinflammatory effects in Chinese over a four year period: A prospective study
T. P. Zheng et al.
ATHEROSCLEROSIS (2014)
DPP-4 Inhibitors Repress NLRP3 Inflammasome and Interleukin-1beta via GLP-1 Receptor in Macrophages Through Protein Kinase C Pathway
Yao Dai et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus
Daniela Justa-Schuch et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
Benjamin M. Scirica et al.
CIRCULATION (2014)
Human Treg Cells Are Characterized by Low/Negative CD6 Expression
Carlos A. Garcia Santana et al.
CYTOMETRY PART A (2014)
Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours
Adam Rainczuk et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Soluble DPP4 originates in part from bone marrow cells and not from the kidney
Zhendi Wang et al.
PEPTIDES (2014)
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs
Fiona M. Keane et al.
FEBS OPEN BIO (2014)
Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurements
Kaat Kehoe et al.
ANALYTICAL BIOCHEMISTRY (2013)
Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
M. Barbieri et al.
ATHEROSCLEROSIS (2013)
DPP-4 inhibitors and atherosclerosis: The promise
Ishwarlal Jialal et al.
ATHEROSCLEROSIS (2013)
Dipeptidyl peptidases in atherosclerosis: expression and role in macrophage differentiation, activation and apoptosis
Veerle Matheeussen et al.
BASIC RESEARCH IN CARDIOLOGY (2013)
Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome
Jofre Tenorio-Laranga et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Contribution of Dipeptidyl Peptidase IV to the Severity of Dextran Sulfate Sodium-Induced Colitis in the Early Phase
Hitoshi Iwaya et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2013)
SDF-1 promotes ox-LDL induced vascular smooth muscle cell proliferation
Ling-Xing Li et al.
CELL BIOLOGY INTERNATIONAL (2013)
Prolyl Endopeptidase-Deficient Mice Have Reduced Synaptic Spine Density in the CA1 Region of the Hippocampus, Impaired LTP, and Spatial Learning and Memory
Giuseppe DAgostino et al.
CEREBRAL CORTEX (2013)
Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
Junichi Matsubara et al.
CIRCULATION JOURNAL (2013)
A Potential Role for Dendritic Cell/Macrophage-Expressing DPP4 in Obesity-Induced Visceral Inflammation
Jixin Zhong et al.
DIABETES (2013)
Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
Tatsuhiko Saito et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
Nasib Ervinna et al.
ENDOCRINOLOGY (2013)
Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer
Julia Tchou et al.
HUMAN PATHOLOGY (2013)
CD26-mediated co-stimulation in human CD8+T cells provokes effector function via pro-inflammatory cytokine production
Ryo Hatano et al.
IMMUNOLOGY (2013)
Prolyl oligopeptidase is a glyceraldehyde-3-phosphate dehydrogenase-binding protein that regulates genotoxic stress-induced cell death
Takashi Matsuda et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction
Hans D. Theiss et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
The SUMO1-E67 Interacting Loop Peptide Is an Allosteric Inhibitor of the Dipeptidyl Peptidases 8 and 9
Esther Pilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Identifying Natural Substrates for Dipeptidyl Peptidases 8 and 9 Using Terminal Amine Isotopic Labeling of Substrates (TAILS) Reveals in Vivo Roles in Cellular Homeostasis and Energy Metabolism
Claire H. Wilson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Dipeptidyl Peptidase IV Is a Human and Murine Neutrophil Chemorepellent
Sarah E. Herlihy et al.
JOURNAL OF IMMUNOLOGY (2013)
Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels
T. Miyagaki et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity
P. A. Spagnuolo et al.
LEUKEMIA (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Tasha E. Fingerlin et al.
NATURE GENETICS (2013)
PROLYL OLIGOPEPTIDASE COLOCALIZES WITH α-SYNUCLEIN, β-AMYLOID, TAU PROTEIN AND ASTROGLIA IN THE POST-MORTEM BRAIN SAMPLES WITH PARKINSON'S AND ALZHEIMER'S DISEASES
M. J. Hannula et al.
NEUROSCIENCE (2013)
Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice
Michishige Terasaki et al.
PLOS ONE (2013)
Targeted Inactivation of Dipeptidyl Peptidase 9 Enzymatic Activity Causes Mouse Neonate Lethality
Margaret G. Gall et al.
PLOS ONE (2013)
Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients
Suncica Buljevic et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis
Shunya Mimura et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver
Sumaiya Chowdhury et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold
Koen Jansen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2013)
Upregulation of SDF-1 is Associated with Atherosclerosis Lesions Induced by LDL Concentration Polarization
Dangheng Wei et al.
ANNALS OF BIOMEDICAL ENGINEERING (2012)
Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor
Albert Mas-Vidal et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2012)
Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP/prolyl oligopeptidase (PREP)-selectivity
Oxana Ryabtsova et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
T. T. Myohanen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Plasma Prolylcarboxypeptidase (Angiotensinase C) Is Increased in Obesity and Diabetes Mellitus and Related to Cardiovascular Dysfunction
Shengyuan Xu et al.
CLINICAL CHEMISTRY (2012)
Influence of a Novel Inhibitor (UM8190) of Prolylcarboxypeptidase (PRCP) on Appetite and Thrombosis
F. M. Rabey et al.
CURRENT MEDICINAL CHEMISTRY (2012)
CD26: A negative selection marker for human Treg cells
Francisco J. Salgado et al.
CYTOMETRY PART A (2012)
Sitagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Psoriasis
Tatsuya Nishioka et al.
DERMATOLOGY (2012)
High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV
C. Marchetti et al.
DIABETOLOGIA (2012)
Sitagliptin reduces plaque macrophage content and stabilises arteriosclerotic lesions in Apoe -/- mice
F. Vittone et al.
DIABETOLOGIA (2012)
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction
Jacob Lonborg et al.
EUROPEAN HEART JOURNAL (2012)
Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report
Kazuki Yokota et al.
INTERNAL MEDICINE (2012)
A Novel SUMO1-specific Interacting Motif in Dipeptidyl Peptidase 9 (DPP9) That Is Important for Enzymatic Regulation
Esther Pilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Human Th17 Cells Express High Levels of Enzymatically Active Dipeptidylpeptidase IV (CD26)
Bertram Bengsch et al.
JOURNAL OF IMMUNOLOGY (2012)
Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN- like proteases in cerebral ischemia
Peter Roehnert et al.
JOURNAL OF NEUROINFLAMMATION (2012)
A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice
Junichi Matsubara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Global identification of peptidase specificity by multiplex substrate profiling
Anthony J. O'Donoghue et al.
NATURE METHODS (2012)
The effect of prolyl oligopeptidase inhibition on extracellular acetylcholine and dopamine levels in the rat striatum
Aaro J. Jalkanen et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice
Michishige Terasaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Structures of Human DPP7 Reveal the Molecular Basis of Specific Inhibition and the Architectural Diversity of Proline-Specific Peptidases
Gustavo Arruda Bezerra et al.
PLOS ONE (2012)
Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury
Veerle Matheeussen et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Dipeptidyl peptidase-4 expression is reduced in Crohn's disease
G. W. Moran et al.
REGULATORY PEPTIDES (2012)
Neutral aminopeptidase and dipeptidyl peptidase IV in the development of collagen II-induced arthritis
Simone Cristina Yamasaki et al.
REGULATORY PEPTIDES (2012)
Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis
Hasan Ulusoy et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner
T. T. Myohanen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis
Zubair Shah et al.
CIRCULATION (2011)
Interaction of Prolyl Oligopeptidase with α-Synuclein
Anne-Marie Lambeir
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research
Anne Penttinen et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2011)
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. F. Deacon
DIABETES OBESITY & METABOLISM (2011)
Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata
Chad E. Brokopp et al.
EUROPEAN HEART JOURNAL (2011)
Neuropeptide Y, B-type natriuretic peptide, substance P and peptide YY are novel substrates of fibroblast activation protein-α
Fiona M. Keane et al.
FEBS JOURNAL (2011)
New aspects of melanocortin signaling: A role for PRCP in alpha-MSH degradation
Sabrina Diano
FRONTIERS IN NEUROENDOCRINOLOGY (2011)
Fibroblast Activation Protein Expression in Crohn's Disease Strictures
Laura Rovedatti et al.
INFLAMMATORY BOWEL DISEASES (2011)
CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy
Fatma Elif Yildirim et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors IMPLICATIONS FOR TUMOR BIOLOGY AND THERAPY
Congyi Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
DPP-4 (CD26) Inhibitor Alogliptin Inhibits Atherosclerosis in Diabetic Apolipoprotein E-Deficient Mice
Nga N. Ta et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Biochemical and Histological Changes in the Small Intestine of Mice With Dextran Sulfate Sodium Colitis
Roger Yazbeck et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Structure-Activity Relationship Studies on Isoindoline Inhibitors of Dipeptidyl Peptidases 8 and 9 (DPP8, DPP9): Is DPP8-Selectivity an Attainable Goal?
Sebastiaan Van Goethem et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
A Novel Role of Dipeptidyl Peptidase 9 in Epidermal Growth Factor Signaling
Tsun-Wen Yao et al.
MOLECULAR CANCER RESEARCH (2011)
The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis
Hiromusu Ban et al.
ONCOLOGY REPORTS (2011)
Soluble CD26/Dipeptidyl Peptidase IV Enhances Human Lymphocyte Proliferation In Vitro Independent of Dipeptidyl Peptidase Enzyme Activity and Adenosine Deaminase Binding
D. M. T. Yu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
Gian Paolo Fadini et al.
VASCULAR PHARMACOLOGY (2011)
DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes
Nga N. Ta et al.
ATHEROSCLEROSIS (2010)
GAP43 shows partial co-localisation but no strong physical interaction with prolyl oligopeptidase
Zoltan Szeltner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients
C. MUSCAT et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Inhibition of multifunctional dipeptidyl peptidase-IV: Is there a risk of oncological and immunological adverse effects?
Tomas Stulc et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Dipeptidyl peptidase 2 apoptosis assay determines the B-cell activation stage and predicts prognosis in chronic lymphocytic leukemia
Alexey V. Danilov et al.
EXPERIMENTAL HEMATOLOGY (2010)
The dipeptidyl peptidase IV family in cancer and cell biology
Denise M. T. Yu et al.
FEBS JOURNAL (2010)
Dipeptidyl Peptidase Expression During Experimental Colitis in Mice
Roger Yazbeck et al.
INFLAMMATORY BOWEL DISEASES (2010)
Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial) - Rationale, design and first interim analysis
Hans D. Theiss et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Jofre Tenorio-Laranga et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Expanding the Dipeptidyl Peptidase 4-Regulated Peptidome via an Optimized Peptidomics Platform
Arthur D. Tinoco et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Acute onset of rheumatoid arthritis associated with administration of a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with diabetes mellitus
Takashi Sasaki et al.
DIABETOLOGY INTERNATIONAL (2010)
Biochemical properties and expression profile of human prolyl dipeptidase DPP9
Hung-Kuan Tang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Biochemistry, pharmacokinetics, and toxicology of a potent and selective DPP8/9 inhibitor
Jia-Jing Wu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
Robert M. Eager et al.
BMC CANCER (2009)
Dipeptidyl peptidase 2 is an essential survival factor in the regulation of cell quiescence
Deanna A. Mele et al.
CELL CYCLE (2009)
Recent insights into the role of dipeptidyl aminopeptidase IV (DPIV) and aminopeptidase N (APN) families in immune functions
Siegfried Ansorge et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice
Dirk Reinhold et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
R. M. Eager et al.
CLINICAL ONCOLOGY (2009)
The Cytoplasmic Peptidase DPP9 Is Rate-limiting for Degradation of Proline-containing Peptides
Ruth Geiss-Friedlander et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Enzyme Activity and Immunohistochemical Localization of Dipeptidyl Peptidase 8 and 9 in Male Reproductive Tissues
Veronique Dubois et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
The In Vivo Expression of Dipeptidyl Peptidases 8 and 9
Denise M. T. Yu et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen
Philip J. O'Reilly et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activity
Elena Di Daniel et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Roger Yazbeck et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers
R. G. van Lingen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2008)
Seprase: An overview of an important matrix serine protease
Pamela O'Brien et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes
R. G. van Lingen et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients
Rosanne G. van Lingen et al.
EXPERIMENTAL DERMATOLOGY (2008)
Stromal cell-derived factors 1α and 1β, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8
Katerina Ajami et al.
FEBS LETTERS (2008)
Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice
Roger Yazbeck et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function
Sabine Wrenger
Frontiers in Bioscience-Landmark (2008)
The role of CD26/dipeptidyl peptidase IV in cancer
Pamela A. Havre et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Prolyl endopeptidase is revealed following SILAC analysis to be a novel mediator of human microglial and THP-1 cell neurotoxicity
Andis Klegeris et al.
GLIA (2008)
Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues
Timo T. Myohanen et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Inhibition of CD26/dipeptidyl CCL11/eotaxin-mediated recruitment peptidase IV enhances of eosinophils in vivo
Ulf Forssmann et al.
JOURNAL OF IMMUNOLOGY (2008)
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation
Amit Gaggar et al.
JOURNAL OF IMMUNOLOGY (2008)
(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (BI 1356), a novel xanthine-based dipeptidyl peptidase 4 inhibitor, has a superior potency and longer duration of action compared with other dipeptidyl peptidase-4 inhibitors
Leo Thomas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
EXPRESSION AND TRAFFIC OF CELLULAR PROLYL OLIGOPEPTIDASE ARE REGULATED DURING CEREBELLAR GRANULE CELL DIFFERENTIATION, MATURATION, AND AGING
M. J. Moreno-Baylach et al.
NEUROSCIENCE (2008)
Prolyl oligopeptidase stimulates the aggregation of α-synuclein
Inger Brandt et al.
PEPTIDES (2008)
The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age
Mirjana Dimitrijevic et al.
PEPTIDES (2008)
Protective effects of GLP-1 analogues exendin-4 and GLP-1(9-36) amide against ischemia-reperfusion injury in rat heart
David P. Sonne et al.
REGULATORY PEPTIDES (2008)
Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function
Kei Ohnuma et al.
TRENDS IN IMMUNOLOGY (2008)
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer
Kalyani Narra et al.
CANCER BIOLOGY & THERAPY (2007)
In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4+ T lymphocytes
T. Ellingsen et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Synergy and antagonism of promiscuous inhibition in multiple-compound mixtures (vol 49, pg 1780, 2006)
Brian Y. Feng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus
A. Nzeusseu Toukap et al.
ARTHRITIS AND RHEUMATISM (2007)
Biology of incretins: GLP-1 and GIP
Laurie L. Baggio et al.
GASTROENTEROLOGY (2007)
Dipeptidyl peptidase II (DPPII), a review
Marie-Berthe Maes et al.
CLINICA CHIMICA ACTA (2007)
Dipeptidyl peptidase 8/9-like activity in human leukocytes
Marie-Berthe Maes et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
On the role of prolyl oligopeptidase in health and disease
J. A. Garcia-Horsman et al.
NEUROPEPTIDES (2007)
Neuropeptide Y (NPY) cleaving enzymes:: Structural and functional homologues of dipeptidyl peptidase 4
Nadine Frerker et al.
PEPTIDES (2007)
Primary prevention of cardiovascular diseases in people with diabetes mellitus - A scientific statement from the American Heart Association and the American Diabetes Association
John B. Buse et al.
CIRCULATION (2007)
Dipeptidyl peptidase IV (DP IV, CD26) and aminopeptidase N (APN, CD13) as regulators of T cell function and targets of immunotherapy in CNS inflammation
Dirk Reinhold et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
The immune response in atherosclerosis: a double-edged sword
Goran K. Hansson et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Dipeptidyl peptidase II and leukocyte cell death
Marie-Berthe Maes et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV
Jais R. Bjelke et al.
BIOCHEMICAL JOURNAL (2006)
Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein
KN Lee et al.
BLOOD (2006)
Soluble CD26 and CD30 levels in CSF and sera of patients with relapsing neuromyelitis optica
K Narikawa et al.
JOURNAL OF NEUROLOGY (2006)
Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis
Denise M. T. Yu et al.
FEBS JOURNAL (2006)
Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes
Stefan Bauer et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes - Potential importance of selectivity over dipeptidyl peptidases 8 and 9
GR Lankas et al.
DIABETES (2005)
Expression of a novel dipeptidyl peptidase 8 (DPP8) transcript variant, DPP8-v3, in human testis
H Zhu et al.
ASIAN JOURNAL OF ANDROLOGY (2005)
Subcellular localization suggests novel functions for prolyl endopeptidase in protein secretion
I Schulz et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
DJ Augeri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse
R Pacheco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Representative aminopeptidases and prolyl endopeptidase from murine macrophages: Comparative activity levels in resident and elicited cells
RA Olivo et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Fluoro-olefins as peptidomimetic inhibitors of dipeptidyl peptidases
P Van der Veken et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7)
MB Maes et al.
BIOCHEMICAL JOURNAL (2005)
Circulating CD26 is negatively associated with inflammation in human and experimental arthritis
N Busso et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine:: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
D Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Prolyl oligopeptidase is involved in release of the antifibrotic peptide Ac-SDKP
MA Cavasin et al.
HYPERTENSION (2004)
Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer
P Busek et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1
K Ohnuma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPIV-like peptidase activity
K Ajami et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2004)
Recombinant prolylcarboxypeptidase activates plasma prekallikrein
Z Shariat-Madar et al.
BLOOD (2004)
Purification, identification and characterisation of seprase from bovine serum
PJ Collins et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
CD26 expression determines lung metastasis in mutant F344 rats:: involvement of NK cell function and soluble CD26
K Shingu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis
HC Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases
SY Qi et al.
BIOCHEMICAL JOURNAL (2003)
1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine:: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties
EB Villhauer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases
K Senten et al.
JOURNAL OF COMBINATORIAL CHEMISTRY (2003)
Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and α-melanocyte-stimulating hormone breakdown in the rat brain
G Bellemère et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Dipeptidyl peptidase IV on activated T cells as a target molecule for therapy of rheumatoid arthritis
YN Williams et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
The expression of T-cell surface antigens CTLA-4, CD26, and CD28 is modulated by inhibition of dipeptidylpeptidase IV (DPP IV, CD26) activity in murine stress-induced abortions
J Rüter et al.
CELLULAR IMMUNOLOGY (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
Murine T cells expressing high activity of prolyl endopeptidase are susceptible to activation-induced cell death
C Odaka et al.
FEBS LETTERS (2002)
Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis
O Bock et al.
EXPERIMENTAL DERMATOLOGY (2001)
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO
T Ishii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease
M Hildebrandt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Comodulation of CXCR4 and CD26 in human lymphocytes
C Herrera et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The binding site of human adenosine deaminase for CD26/dipeptidyl peptidase IV: The Arg142Gln mutation impairs binding to CD26 but does not cause immune deficiency
E Richard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8
CA Abbott et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Dipeptidyl peptidase IV (DP IV/CD26) mRNA expression in PWM-stimulated T-cells is suppressed by specific DP IV inhibition, an effect mediated by TGF-β1
M Arndt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Down-regulation of T cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the thromboxane A2 receptor
S Wrenger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation
H Ikushima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expression
J Blanco et al.
FEBS LETTERS (2000)
Thioxo amino acid pyrrolidides and thiazolidides:: new inhibitors of proline specific peptidases
A Stöckel-Maschek et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Molecular analysis of CD26-mediated signal transduction in T cells
J Hühn et al.
IMMUNOLOGY LETTERS (2000)
分享论文
